|
|
|
|
|
by sinab
1837 days ago
|
|
I read this essay with interest as I work at the intersection of biology and engineering; I was disappointed. The essay fails to identify low-hanging fruit in automating biology and fails to explain how their company (Transistor Bio) is "picking" those low-hanging fruit. In retrospect it reads more like a poorly argued marketing pitch than an exposition on interesting and achievable problems in biology automation. The company's website also leaves much to be desired; though they have reinvented the liquid handling robot [1]. [1] https://publish.obsidian.md/serve?url=transistor.bio/busines... |
|
We have thrown far more money to adware-crap-companies of what we have thrown to systems biology startups, even if only the later can have a meaningful impact on human health.